Wave Life Sciences Ltd.
WVE
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.12B
Close$
$0.19
96.7% downside
Current Fair Value
96.7% downsideOvervalued by 96.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.12 Billion |
|---|---|
| Enterprise Value | $600.30 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.21 |
| Beta | -1.3 |
| Outstanding Shares | 200,167,869 |
Return
| Return on Equity | -35.88% |
|---|---|
| Return on Assets | -31.46% |
| Return on Invested Capital | -35.80% |
Valuation & Multiples
| P/E Ratio | -5.49 |
|---|---|
| PEG | 12.38 |
| Price to Sales | - |
| Price to Book Ratio | 2.89 |
| Enterprise Value to Revenue | 8.36 |
| Enterprise Value to EBIT | -3.14 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0.04 |
| Debt to Equity | 0.05 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 14, 2026
EPS Estimate
$-0.34
Average shareholder expectationRevenue Estimate
$8.45 M
Average shareholder expectationNext Earnings Call
Expected Date
July 29, 2026
EPS Estimate
$-0.37
Average shareholder expectationRevenue Estimate
$7.66 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 31.47% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.40%▼ 95.46% |
|---|---|
| Total Invested | $4.69M▼ 99.62% |
| Investors Holding | 15▼ 238.00% |
ESG Score
No data
About Wave Life Sciences Ltd.
CEO: Paul Bolno